Services
Type of Care
- Substance use treatment
- Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders
Service Settings
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Telemedicine/telehealth
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
Type of Opioid Treatment
- Buprenorphine maintenance
- Prescribes buprenorphine
- Administers naltrexone
- Relapse prevention from naltrexone
Pharmacotherapies
- Buprenorphine sub-dermal implant (Probuphine®)
- Buprenorphine with naloxone (Ex. Suboxone®)
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable, for example, Sublocade®)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone (Vivitrol®))
- Medications for HIV treatment
- Medications for Hepatitis C treatment
- Clonidine
Treatment Approaches
- Motivational interviewing
Facility Operation (e.g., Private, Public)
- Private for-profit organization
Payment/Insurance/Funding Accepted
- Federal, or any government funding for substance use programs
- Medicare
- Medicaid
- Military insurance (e.g., TRICARE)
- Private health insurance
- State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
- Adult women
- Adult men
Assessment/Pre-treatment
- Outreach to persons in the community
Screening & Testing
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- HIV testing
- Screening for Hepatitis C
- Screening for substance use
- STD testing
Transitional Services
- Naloxone and overdose education
Tobacco/Screening Services
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
Facility Smoking Policy
- Smoking not permitted
Age Groups Accepted
- Adults
- Young adults
Gender Accepted
- Female
- Male